2Illoh OC. Current applications of flow cytometry in the diagnosis of primary immunodeficiency diseases. Arch Pathol Lab Med, 2004, 128:23-31.
3Freyer DR, Gowans LK, Warzynski M, et al. Flow cytometfic diagnosis of X-linked hyper-IgM syndrome: application of an accurate and convenient procedure. J Pediatr Hematol Oncol, 2004, 26:363-370.
4O'Gorman MR. Role of flow cytometry in the diagnosis and monitoring of primary immunodeficiency disease. Clin Lab Med, 2007, 27 : 591-626.
5Scholl PR, O'Gorman MR, Pachman LM,et al. Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant,1998,22(12):1215-1218.
6Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disease
7Sacco MG, Ungari M, Cato EM,et al. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. Cancer Gene Ther, 2000,7(10):1299-1306.
8Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol, 1994, 153:1027-1036.
9Jain A, Atkinson TP,Lipsky PE,et al. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.J Clin Invest, 1999,103:1151-1158.
10Minegishi Y, Lavoie A, Cunningham-Rundles C,et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol, 2000,97(3):203-210.
